Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marrow transplantation for acute leukemia.

E D Thomas

    Cancer
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Marrow transplantation offers a path to cure acute leukemia by overcoming chemotherapy limits. Leukemia-free survival after 2 years suggests a potential cure for many patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.

    Transplantation·1992
    Same author

    Methylation of the DXS255 hypervariable locus 5' CCGG site may be affected by factors other than X-chromosome activation status.

    Genomics·1992
    Same author

    Bone marrow transplantation: past experiences and future prospects.

    Seminars in oncology·1992
    Same author

    Donor alloreactivity may predict acute graft-versus-host disease in HLA-matched bone marrow transplantation for leukemia in early remission.

    European journal of haematology·1992
    Same author

    Mixed leukocyte culture reactivity and graft-versus-host disease in HLA-identical marrow transplantation for leukemia.

    Bone marrow transplantation·1992
    Same author

    Acceptance of the George M. Kober Medal.

    Transactions of the Association of American Physicians·1992

    Area of Science:

    • Hematology
    • Oncology
    • Immunology

    Background:

    • Chemotherapy for leukemia is limited by marrow toxicity.
    • Marrow transplantation can overcome these limitations, enabling new therapeutic strategies.
    • Acute leukemia remains a significant challenge in hematologic oncology.

    Purpose of the Study:

    • To summarize outcomes of marrow transplantation for end-stage acute leukemia.
    • To evaluate the efficacy and safety of allogeneic and syngeneic marrow transplantation.
    • To define an operational cure for leukemia based on long-term survival post-transplant.

    Main Methods:

    • Analysis of 154 cases of end-stage acute leukemia treated with marrow transplantation.
    • Evaluation of graft-versus-host disease incidence and severity in allogeneic transplants.

    Related Experiment Videos

  • Kaplan-Meier and actuarial plots to assess leukemia recurrence and survival rates.

    • Main Results:

    • Graft-versus-host disease occurred in ~2/3 of allogeneic transplant recipients, severe in ~20%.
    • Leukemia recurrence was observed in ~2/3 of patients within 2 years post-transplant.
    • No leukemia recurrence was noted after 2 years, with a stable survival curve from 2-7 years.

    Conclusions:

    • Marrow transplantation is a viable strategy for end-stage acute leukemia.
    • Long-term leukemia-free survival post-transplantation defines an operational cure.
    • Further research into mitigating graft-versus-host disease is warranted.